Search

everythinglearnresearchcommunity

for

Search:↓

Actinic keratosis can lead to skin cancer, is more common in fair-skinned people, and can be reduced with sunscreen and treated effectively.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Scalp cooling reduces chemotherapy-induced hair loss without increasing risk of skin metastases.

Polycystic Ovary Syndrome (PCOS) is a complex disorder with both immediate and long-term health effects, including menstrual issues, infertility, and increased risk of diabetes and heart disease.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

Fat tissue cells are a promising option for healing various diseases, but more research is needed to ensure they are safe and effective.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Children are at risk of health issues from exposure to platinum group elements from car exhausts.

Obese women with PCOS are more likely to have fatty liver disease.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

CT scans can find serious prostate cancer even when PSA levels are low.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Women with aging signs and heart issues have higher hair loss risk, which may predict shorter lifespan and affect attractiveness.